Name Development Level Target Family
Sodium channel protein type 10 subunit alpha Tclin Ion Channel
Sodium channel protein type 3 subunit alpha Tclin Ion Channel
Sodium channel protein type 11 subunit alpha Tclin Ion Channel
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A Tclin Enzyme
Gamma-aminobutyric acid receptor subunit alpha-1 Tclin Ion Channel
cAMP-specific 3',5'-cyclic phosphodiesterase 4A Tclin Enzyme
Sodium channel protein type 8 subunit alpha Tclin Ion Channel
Muscarinic acetylcholine receptor M1 Tclin GPCR
cAMP-specific 3',5'-cyclic phosphodiesterase 4B Tclin Enzyme
cAMP-specific 3',5'-cyclic phosphodiesterase 4C Tclin Enzyme
cAMP-specific 3',5'-cyclic phosphodiesterase 4D Tclin Enzyme
Muscarinic acetylcholine receptor M2 Tclin GPCR
Sodium channel protein type 4 subunit alpha Tclin Ion Channel
Sodium channel protein type 1 subunit alpha Tclin Ion Channel
Gamma-aminobutyric acid receptor subunit beta-2 Tclin Ion Channel
cAMP-specific 3',5'-cyclic phosphodiesterase 7B Tclin Enzyme
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B Tclin Enzyme
Muscarinic acetylcholine receptor M3 Tclin GPCR
Sodium channel protein type 5 subunit alpha Tclin Ion Channel
Sodium channel protein type 9 subunit alpha Tclin Ion Channel
Gamma-aminobutyric acid receptor subunit gamma-2 Tclin Ion Channel
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A Tclin Enzyme
Sodium channel protein type 7 subunit alpha Tclin Ion Channel
Sodium channel protein type 2 subunit alpha Tclin Ion Channel
Name Description
phenazopyridine A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
TCRDv4.6.0
DrugCentral Indication
DrugCentral
phenazopyridine